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Investigation of an acute gastroenteritis outbreak
involving >100 persons at a summer camp in Girona,
Spain, in June 2002 led to the detection of Salmonella
enterica and extended-spectrum cephalosporin-resistant
Escherichia coli (ESCREC). Stool cultures were performed
for 22 symptomatic campers, three asymptomatic food
handlers, and 10 healthy household members. Of the 22
campers, 19 had Salmonella enterica, 9 had an ESCREC
strain carrying an extended-spectrum β-lactamase, and 2
had a second ESCREC strain carrying a plasmidic
cephamycinase. Related ESCREC were detected in two
(salmonella-negative) asymptomatic food handlers and in
none of the healthy household members. Fecal ESCREC
and its β-lactamases and plasmids were extensively char-
acterized. Three of the five ESCREC clones were recov-
ered from multiple hosts. The apparent dissemination of
ESCREC suggests a food or water vehicle. The observed
distribution of resistance plasmids and β-lactamase genes
in several clones indicates a high degree of horizontal
transfer. Heightened vigilance and increased efforts must
be made to discover the reservoirs and vehicles for com-
munity dissemination of ESCREC.
S
trains of Escherichia coli that produce enzymes capa-
ble of degrading extended- spectrum cephalosporins
(ESCs), i.e., extended-spectrum β-lactamases (ESBLs), or
these drugs plus cephamycins, i.e., plasmidic or hyperpro-
duction of chromosomal cephamycinases have recently
emerged as important nosocomial pathogens (1,2). Some
of these strains cannot be reliably detected by clinical
microbiology laboratories by using conventional suscepti-
bility tests (3), and even when recognized, treating infec-
tions caused by these strains can be challenging because
therapeutic options are limited. Infections attributable to
such strains are associated with prolonged hospital stays,
increased healthcare costs, and an increased number of
deaths if appropriate therapy is delayed (4,5).
To date, almost all reports of infection or colonization
with ESBL- and plasmidic cephamycinase-producing E.
coli (i.e., extended-spectrum cephalosporin-resistant E.
coli [ESCREC]) have involved hospitalized patients or
nursing home residents (3,6). The few reported patients
with community-acquired infection have been elderly and
debilitated and have had hospital contact, important coex-
isting conditions, or both (3,6). 
E. coli, including resistant strains, may be transmitted
within the community through the food supply. Indeed,
other gram-negative enteric pathogens, notably Salmonella
enterica, are a frequent cause of foodborne disease and,
increasingly, are associated with antibiotic resistance,
including antibiotic resistance to ESCs (7–11). Available
data regarding other resistant E. coli suggest that ESCREC
could also be disseminated through the food supply
(12–19). 
The cefoperazone-containing medium routinely used in
our laboratory for the isolation of Campylobacter occa-
sionally yields other bacteria with hyperproduction of
chromosomal β-lactamases or their plasmidic derivatives,
as well as strains carrying extended-spectrum β-lactamases
(unpub. data). By using this media, we have isolated sever-
al resistant enterobacteriaceae strains from patients with
sporadic cases of gastroenteritis (unpub. data). During an
investigation of a summer camp-associated salmonellosis
outbreak, we observed that stool cultures from nine
campers unexpectedly yielded, on cefoperazone-contain-
ing medium, colonies resembling enterobacteriaceae, with
a uniform mucoid appearance. This result suggested the
possibility that the same, probably ESC-resistant, enter-
obacterial strain was present in all these persons, findings
consistent with possible foodborne spread. Consequently,
all samples were reevaluated on media containing cefo-
taxime (see Methods) to increase sensitivity for detection
of ESC-resistant organisms. To gain more knowledge of
foodborne spread as a potential mechanism of dissemina-
tion of resistance genes, we undertook an extensive molec-
ular epidemiologic analysis of these isolates. 
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Description of the Outbreak and Stool Sampling
Two hundred twenty-five elementary and secondary
school students and 11 teachers were spending a week
(June 11–15, 2001) at a summer camp in Palafrugell,
Girona (Spain), when an outbreak of gastroenteritis began
on June 14. An epidemiologic investigation involving 200
campers and staff failed to identify the source of the out-
break. Clinical and epidemiologic studies were initiated at
the onset of the outbreak, but our participation as reference
laboratory began later. Consequently, a limited number of
stools from symptomatic patients and related persons were
available to us for analysis.
From June 16 to 19, stool samples from 22 ill campers
were collected for analysis. On July 6 (18–19 days later),
additional stool samples were collected from four ill
campers and from 10 asymptomatic household members
of the four ill campers. Stool samples were also collected
from three asymptomatic food handlers, on June 19, 22,
and 28.
Microbiologic Studies
Human Samples 
Stool samples were processed according to convention-
al protocols for isolation of enteropathogenic bacteria, in
addition to special selection for resistant organisms (as
described below). Isolates were identified by conventional
methods (20). Stools (fresh and after modified Ziehl-
Neelsen staining) were microscopically examined for pro-
tozoa (21). Latex agglutination was used to detect
rotavirus  immunochromatography to dectect adenovirus
40/41, and reverse transcriptase–polymerase chain reac-
tion (RT-PCR) (22) to detect calicivirus.
Selection of ESCREC
Stool suspended in saline was added to trypticase soy
broth containing 2 mg/L cefotaxime (TSB-CTX), which
after 18 h of incubation at 35°C, was added to similarly
supplemented MacConkey broth (MacC-broth-CTX).
After an 18-h incubation, a loopful of this broth was spread
on similarly supplemented MacConkey agar. A colony of
each distinct morphotype was analyzed further.
Selection of Resistant S. enterica Strains
Stool samples were processed as for isolation of
ESCREC, but after the initial growth the MacC-broth-
CTX was added to selenite broth. After 8 h of incubation
at 35°C, this broth was spread on cefotaxime-supplement-
ed xylose-lysine-deoxycholate agar. Colonies suspected  of
representing Salmonella were analyzed further.
Food Studies
Eight unprepared food items from the camp kitchen
were analyzed for Salmonella and ESCREC as described
for stool samples, except that the initial TSB-CTX was
replaced by peptone yeast extract broth.
Antibiotic Susceptibility Testing
Disk diffusion susceptibility testing to 28 antibiotics
(Table) was performed according to National Committee
for Clinical Laboratory Standards (NCCLS) guidelines
(23). The activity of cefotaxime and ceftazidime, com-
bined with clavulanate, was determined by E test (AB
Biodisk, Solna, Sweden). MICs to β-lactam antibiotics
were determined by broth microdilution (Sensititre, Trek
Diagnostic Systems LTD, West Sussex, England), accord-
ing to NCCLS guidelines (24,25).
Transfer of Resistance Determinants
Filter matings were performed with ESCREC donors,
using as recipients either E. coli HB101 (Nal Kan) for
which transconjugants were selected, according to
described methods (26), or the S. enterica isolate from
patient P12, for which transconjugants were selected by
adding the filter containing mixed growth of E. coli and
Salmonella to MacC-broth-CTX. This broth, which was
subsequently processed as described above for selection of
resistant S. enterica. 
Extraction of β β-Lactamases 
and Isoelectric Focusing (IEF)
Crude extracts of β-lactamases were obtained by ultra-
sonication. Analytical IEF was performed as previously
described (27).
Characterization of β β-Lactamase Genes
The bla
TEM, blaCTX-M-9 and blaCMY-2 genes were ampli-
fied as previously described (28–33). The DNA sequence
was directly determined from PCR products for both DNA
strands (34).
Biotyping and Serotyping
The biotype, as determined for 12 metabolic reactions,
was expressed as a 4-digit code (35). The serotype and
phage type of Salmonella isolates were determined in the
Servicio de Enterobacterias del Centro Nacional de
Microbiología, Instituto Carlos III, Majadahonda, Spain
(M.A. Usera and A. Echeita). The serogroup of the
ESCREC was determined at the Laboratorio de Referencia,
Lugo, Universidad de Santiago de Compostela (J. Blanco).
Pulsed-Field Gel Electrophoresis (PFGE)
Genomic profiles were analyzed by PFGE with XbaI
(Amersham Biosciences UK Limited, Buckinghamshire,
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PFGE profiles were considered to represent the same
clone. 
Plasmid Profiles Analysis 
Plasmid DNA was isolated by using a commercial kit
(QIAGEN, Inc., Valencia, CA) and subjected to 0.8%
agarose gel electrophoresis both without digestions and
after cleavage with PstI,  SmaI, or HincII (Amersham
Biosciences). For southern hybridization (38), both total
and restricted plasmid DNA were transferred to nylon
membranes and hybridized with PCR-generated probes for
blaCTX-M-9 (850 bp) and blaCMY-2 (1,017 bp), as labeled and
detected using the ECL Direct Nucleic Acid Labeling and
Detection System (Amersham Biosciences).
Statistical Methods
Comparisons of proportions were tested by using the
Fisher exact test (two-tailed).
Results
Epidemiologic Survey
The 225 student campers, 10–16 years of age, and 11
teachers were from three schools in three cities, Tarragona
(T), El Prat (EP), and Sant Boi (SB). Of the 200 campers
and staff interviewed, 109 (54.5%), including 3 teachers,
had symptoms of gastroenteritis, with no significant differ-
ences between the three schools (57%, 49%, and 62%
respectively). The most frequent symptoms were abdomi-
nal pain (80%), diarrhea (79%), and headache (64%). Two
students were admitted to hospital, but after supportive
therapy were discharged within 48 hours. No person
received antibiotic therapy.
Microbiologic Study
Campers
Of the 109 ill campers, 22 provided stool samples that
were available for microbiologic study in our laboratory.
Nineteen (86%) of the acute-phase stool samples yielded
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Table. Characteristics of 15 extended-spectrum cephalosporin-resistant fecal Escherichia coli isolates derived from an outbreak of 
salmonellosis 
Southern blot 
pattern 
Patient no. 
(age in y)  School
b  Isolate  Isolation date  Biotype  Serotype 
PFGE 
pattern 
(clone) 
Plasmid 
profile  PstI 
SmaI / 
HincII
c  β-lactamase 
Associated 
resistance
d 
P5
a (12)  EP  1  06-18-01  5671  NT  A  I a
e  1  a  CTX-M-9  Tp, Sxt 
P6
a (11)  EP  1  06-18-01  5671  NT  A  I b
e  2  b  CTX-M-9  Tp, Sxt 
P9
a (12)  SB  1  06-19-01  5671  NT  A  I c
e  2  b  CTX-M-9  Tp, Sxt 
SB  1  06-19-01  5671  NT  A  I a
e  3  c  CTX-M-9  Tp, Sxt  P10
a (12) 
  2  06-19-01  7775  O:86  B  II a
e  4  d  CMY-2  Tp, Sxt, Cm, 
Fur 
SB  1  06-19-01  5671  NT  A  I b
e  3  b  CTX-M-9  Tp, Sxt  P12
a (11) 
  2  07-06-01  5671  NT  A  I b
e  3  b  CTX-M-9  Tp, Sxt 
P14
a (12)  SB  1  06-19-01  1571  O:20  C  III  3  e  CTX-M-9 + 
TEM-1 
Tp, Sxt, Km, 
Neo 
P15 (11)  SB  1  06-19-01  0371  O:145  D  IV  3  f  CTX-M-9 + 
TEM-1 
Tp, Sxt, Cm 
SB  1  06-19-01  5671  NT  A  I b
e  3  b  CTX-M-9  Tp, Sxt  P18
a (11) 
  2  06-19-01  7775  O:86  B  II b
e  4  d  CMY-2  Cm, Fur 
P19
a (12)  T  1  06-19-01  5671  NT  A  I b
e  3  b  CTX-M-9  Tp, Sxt 
F2    1  06-22-01  1571  O:20  C  V  4  nd
f  CTX-M-9 + 
TEM-1 
Tp, Sxt, Km, 
Neo 
  1  06-22-01  4571  O:55  E  VI  4  d  CMY-2 + 
TEM-1 
Cm, Gm, Km, 
Neo, Tob 
F3 
  2  06-28-01  4571  O:55  E  VI  4  d  CMY-2 + 
TEM-1 
Cm, Gm, Km, 
Neo, Tob 
aSalmonella enterica also was isolated. 
bSB, Sant Boi; T, Tarragona; EP, El Prat. 
cThe SmaI RFLP pattern was determined for those strains carrying the CTX-M-9 enzyme and the HincII RFLP pattern was determined for those carrying the CMY-2 
enzyme. 
dAll ESCREC isolates were resistant to all penicillins and cephalosporins, including ESCs, as well as to nalidixic acid, tetracycline, sulfonamides and streptomycin. Other 
antibiotics tested included ampicillin, amoxicillin-clavulanate, piperacillin, cefazolin, cefuroxime, cefoxitin, cefotaxime, ceftazidime, cefepime, aztreonam, imipenem, 
chloramphenicol (Cm), gentamicin (Gm), kanamycin (Km), tobramycin (Tob), amikacin, neomycin (Neo), sulfamethoxazole-trimethoprim (Sxt), trimethoprim (Tp), 
ciprofloxacin, fosfomycin, nitrofurantoin, rifampin and furazolidone (Fur).  
eThe only difference between the Ia, Ib, and Ic, or the IIa and IIb plasmid profiles is one band higher than 100 kb within the particular plasmid pattern. 
fnd, not determined. S. enterica serovar Enteritidis phage type 4, which was sus-
ceptible to all tested antimicrobial agents. No fecal
pathogens were detected in the remaining three ill campers. 
In addition, ESCREC were isolated from the initial
stool sample for 9 (41%) of the 22 campers, including 8
(42%) of 19 with salmonellae and 1 with no detectable
enteric pathogen (Table). All nine samples contained an
ESCREC isolate resistant to penicillins and cephalosporins
(including ESCs) but susceptible to cephamycins and car-
bapenems (CTXR-FOXR-ESCREC), consistent with pro-
duction of an ESBL. Two of these samples also yielded a
second ESCREC type that was resistant to penicillins and
cephalosporins, including ESCs and cephamycins, but sus-
ceptible to carbapenems (CTXR-FOXR-ESCREC), consis-
tent with hyperproduction of E. coli AmpC chromosomal
β-lactamase or presence of a plasmidic cephamycinase. All
ESCREC isolates exhibited multiple additional resistance
markers (Table).
Follow-up stool samples (collected 18–19 days later)
were available for four campers. Neither salmonellae nor
ESCREC was recovered, except in one camper, from
whom the initial ESCREC strain was isolated (Table). 
Food Handlers and Households Contacts
Although stool samples collected from the three
(asymptomatic) food handlers were negative for
enteropathogens, two of these persons were carriers of
ESCREC. One had CTXR-FOXS-ESCREC at the second
sampling, whereas the other had CTXR-FOXR-ESCREC at
both the second and third samplings. 
In contrast, neither enteropathogens nor ESCREC were
detected in stool samples from 10 healthy household mem-
bers of four ill campers who had both ESCREC and salmo-
nellae in their acute-phase stool sample (for prevalence of
ESCREC among household members vs. campers or food
handlers, p=0.03 and p=0.04, respectively). 
The eight cultured camp food items yielded neither S.
enterica serovar Enteritidis nor ESCREC.
E. coli β β-Lactamases
In the 11 E. coli isolates phenotypically suspected of
ESBL production, a β-lactamase with an isoelectric point
of 8.0 was detected. PCR with blaCTX-M-9-specific primers
and sequence analysis confirmed the presence of the CTX-
M-9 β-lactamase (not shown).
Three of these isolates had an additional β-lactamase
with pI 5.4, which in IEF reacted with penicillin but not
with ceftriaxone. PCR with blaTEM-specific primers con-
firmed the presence of a TEM-1-like β-lactamase (Table).
All four isolates phenotypically suspected of AmpC β-
lactamase production were PCR-positive with ampC-fam-
ily primers. Sequence analysis confirmed the presence of
the CMY-2 β-lactamase (not shown).
Biotyping, Serotyping, 
and PFGE Analysis of Isolates
Collectively, the 15 ESCREC isolates represented five
distinct biotypes (Table). Overall, five serogroups (O20,
O55, O86, O145, and non-typable/NT) and five PFGE pul-
sotypes (A to E) were detected. Biotype, serogroup, and
pulsotype corresponded precisely, confirming the presence
of five discrete ESCREC clones (Table and Figure 1). 
Epidemiologic Distribution of Clones
Clone A(CTX-M-9), the most prevalent, was recovered
from students from all three cities, EP, SB, and T (Table).
Clone B (CMY-2) was recovered from two students from
Sant Boi and clone E (also CMY-2) was recovered from a
food handler. Clone C (CTX-M-9 + TEM-1) was recov-
ered from both a Sant Boian student and a food handler.
Clone D (CTX-M-9 + TEM-1) was recovered from a Sant
Boian student.
Plasmid Analysis 
Plasmid profiles of the ESCREC isolates were largely
concordant with clonal assignments (Figure 2A, Table). In
all but one isolate, the probes for blaCTX-M-9 and blaCMY-2
hybridized to a single large (>150 kb) plasmid (Figure 2).
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Figure 1. Restriction pattern (XbaI) by pulsed-field gel elec-
trophoresis of the five extended-spectrum, cephalosporin-resistant
Escherichia coli clones (A, B, C, D, E). mw: marker. By Southern blot analysis, the blaCTX-M-9-containing
plasmids (clones A, C, and D) exhibited minor diversity
within and greater diversity among clones (Figures 2–4,
Table). In the uncut plasmid blot, the large, probe-positive
plasmids of clones A and D were uniform in size and larg-
er than those of clone C (Figure 2B). The corresponding
PstI Southern blot showed three different patterns, which
were not clone-specific (Figure 3, Table). All of these iso-
lates exhibited a band at ~1,289 bp (Figure 3B), whereas
three isolates (all clone A) also exhibited a variably sized
larger band (Figure 3B, Table). The corresponding SmaI
blot showed five patterns among the CTX-M-9-positive
isolates, including three closely related patterns among the
clone A isolates and unique patterns each for the clone C
and D isolates (Figure 4, Table). 
In contrast, the blaCMY-2-containing isolates (clones B
and E) were indistinguishable in both the uncut plasmid
blot (Figure 2C) and the PstI and HincII blots, which
showed a homogeneous single-band pattern for all three
isolates (not shown).
Transfer of Resistance in vitro 
One CTX-M-9-positive isolate transferred its resistance
by in vitro conjugation to E. coli HB101 but not to a S.
enterica isolate from a patient. In contrast, a CMY-2-posi-
tive isolate was successfully conjugated with this S. enter-
ica isolate but not with E. coli HB101 (probably due to the
donor strain’s production of a bacteriocin that inhibits
HB101; data not shown). 
Discussion
Our microbiologic evaluation of an outbreak of
Salmonella gastroenteritis at a summer camp uncovered
the unsuspected dissemination among campers and camp
staff of multiple clones of ESCREC containing diverse
conjugally transferable β-lactamases. Several lines of evi-
dence indicated that dissemination of ESCREC occurred
within the summer camp. Sharing of ESCREC clones was
observed among multiple hosts who had no contact with
one another before camp, yet at camp lived together and
shared a common food and water supply. Isolation of
ESCREC was limited to camp attendees, to the exclusion
of members of the campers’households who did not attend
camp. Finally, the high observed prevalence of fecal
ESCREC among camp attendees (11/25, 44%) contrasts
strikingly with the low prevalence of ESCREC detected by
using similar methods in reference fecal samples from 707
outpatients without an infectious disease diagnosis who
attended Sant Pau Hospital from February through May,
2001 (2%: p<0.001; [39]) and among E. coli isolates from
our hospital clinical microbiology laboratory (e.g., in
2000, for CTX-M-9, 0.5%; for CMY-2, 0.2%) (29).
The mechanism for dissemination of ESCREC within
the camp remains undefined. Direct person-to-person
spread is possible but seems unlikely, since transmission to
household members after campers returned home was not
evident, as would be expected if domestic contact could
lead to transmission. However, hygienic conditions con-
ceivably were worse at the camp, particularly during the
outbreak of gastroenteritis. 
The concurrent outbreak of salmonellosis, a classic
foodborne pathogen, suggested that contaminated food (or
possibly water) might have served as a vehicle for
ESCREC within the camp. Indeed, ESCREC clones A and
B were confined to hosts who also had salmonellae. Since
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Figure 2. Plasmid profile (A) and hybridization with CTX-M-9 probe
(B) and CMY-2 probe (C). The studied isolates, by lane, are: 1: P5,
2: P6, 3: P6T (transconjugant of P6), 4: P9, 5: P10-1, 6: P12-1, 7:
P12-2, 8: P14, 9: P15, 10: P18-1, 11: P19, 12: F2, 15: P10-2, 16:
P18-2, 17: P18-2T (transconjugant of P18-2), 18: F3-1, 13, and 14:
plasmid control strains E. coli 678 CECT (= NCTC 50193 with the
following plasmid sizes: 54.38, 7.30, 5.56, 5.14, 3.98, 3.08, 2.71,
and 2.06 kb) and E. coli 679 CECT (= NCTC 50192 with the fol-
lowing plasmid sizes: 148.5, 63.8, 36.2 and 7 kb.). M is marker III
(Roche Diagnostics GmbH, Mannheim, Germany). Below each
lane in panel A is indicated the plasmid profile designation shown
in the Table.
Figure 3. Plasmid restriction with PstI (A) and hybridization of iso-
lates carrying the CTX-M-9 enzyme with the CTX-M-9 probe (B).
The isolates are as listed in Figure 1. Below each line of hybridiza-
tion, the pattern shown in the Table is indicated.only eight food items were cultured, the failure to recover
ESCREC from camp foods provides little evidence to rule
out foodborne transmission.
Although food handlers have been implicated in many
foodborne outbreaks of intestinal disease (40), in this
instance they appeared an unlikely source for either
ESCREC or salmonellae. None of the three food handlers
was colonized with salmonellae or with ESCREC clones
A, B, or D, all of which were present in one or more
campers, whereas one food handler had a unique ESCREC
clone (clone E), one shared a distinct ESCREC clone
(clone C) with a single camper, and one had no detectable
ESCREC. Thus, if food were the vehicle, the contamina-
tion most likely occurred before the food’s arrival at the
camp, i.e., during production, processing, or transport.
Since CMY-2 is closely associated with food animals, the
present CMY-2-positive ESCREC plausibly could be of
food animal origin. In contrast, CTX-M-9 and other
ESBLs have been described only in humans. Thus, their
presence suggests a human source of contamination.
Plasmid analysis indicated that although distinctive
CTX-M-9-encoding plasmids were present in clones A, C,
and D, the constituent blaCTX-M-9 genes clearly derived
from a common source, as demonstrated by their internal
sequence identity and conserved flanking PstI sites,
despite the diversity of flanking SmaI sites. Minor within-
clone diversity was evident among the blaCTX-M-9-contain-
ing plasmids of clones A and C, consistent with recent
microevolution. In contrast to the CTX-M-9-positive
clones, clones B and E appeared to share the same blaCMY-
2-containing plasmid, consistent with recent horizontal
transfer. Since clone B was isolated from two different
hosts, it presumably acquired the CMY-2 plasmid before
dissemination. By contrast, since clone E was recovered
from only one host, the timing of its acquisition of the
plasmid could not be determined. The diffusion of indis-
tinguishable plasmids between different clones and the
presence of similar but distinct plasmids within the same
clone indicate the rapid biological dynamics of plasmids
(9,10).
Conjugal transfer in vitro of broad-spectrum β-lacta-
mases was achieved from ESCREC isolates to both a lab-
oratory strain of E. coli (CTX-M-9) and an outbreak S.
enterica isolate (CMY-2). These findings, which are con-
sistent with our previous work and that of others (30,31),
suggest that intraspecies or intergeneric transfer of broad-
spectrum β-lactamases could occur in nature, either in vivo
(in humans or animals) or in an inanimate reservoir (e.g.,
sewage or manure) (9,10). Thus, ESCREC may pose a
threat both because of their direct potential for causing
drug-resistant infections and because they can serve as
vector of resistance elements for transmission to other
pathogens or opportunistic microorganisms.
Our findings provide novel evidence of the dissemina-
tion of ESCREC among otherwise healthy persons.
Moreover, in two persons ESCREC strains were docu-
mented to persist for at least 6 days or 17 days, suggesting
possible establishment of stable colonization. Although no
drug-resistant E. coli infections were known to have result-
ed from this dissemination, the data nonetheless suggest
the possibility of widespread future emergence within the
community of E. coli that is resistant to ESCs and of the
responsible resistance genes, which could have substantial
adverse health consequences (4,5). 
Limitations of this study include the modest sample
size (particularly for household members), short longitudi-
nal follow-up, unusual circumstances (concurrent salmo-
nellosis outbreak, summer camp setting), and absence of
data regarding prior antibiotic use and hospital contact.
Future studies should seek ESCREC in a similar setting,
and in the general community, during a period without a
known infectious disease outbreak. 
In summary, our microbiologic evaluation of an out-
break of Salmonella gastroenteritis at a summer camp
showed the unsuspected dissemination among campers
and staff of multiple clones of ESCREC that contained
diverse, conjugally transferable β-lactamases. Dissemin-
ation of ESCREC within the summer camp, possibly
through food or water, was suggested by several lines of
evidence. Confirmation of community-based transmission
of ESCREC in other contexts and locales would indicate a
need for heightened vigilance and efforts to discover the
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Figure 4. Plasmid restriction with SmaI (A) and hybridization of iso-
lates carrying the CTX-M-9 enzyme with the CTX-M-9 probe (B).
The isolates are as listed in Figure 1. Below each line of hybridiza-
tion, the pattern shown in the Table is indicated.reservoirs and vehicles for dissemination of ESCREC
within the community.
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